医疗

最大限度利用机遇

我们与处于全球医疗革命前沿的企业家和投资者密切合作。我们将深入的行业知识与技术能力相结合,使我们能帮助企业和投资者在寻求巩固和发展其市场地位时,充分利用整个行业的巨大机遇。

人口老龄化、技术变革以及人们对医疗保健产品和服务的需求增加,所有这些为健康和社会护理、医疗设备、生命科学、生物科学和医药市场创造了前所未有的机遇。我们的工作是帮助客户最大限度地利用这些机遇。

< >

我们的最新交易

Clearwater在领导世界各地候选人参与过程中表现非常专业。

Luc Bertholat,Naxicap Partners合伙人

Our 医疗 Team

该团队很快就为我们找到合适的合作伙伴,并借助他们与买方的良好关系协助谈判,达成了实现我们目标的交易。
Dan Smart, CEO, Proclinical

凭借深厚的知识和技术能力,我们的医疗团队在提供量身定制的解决方案方面一直表现优异。

查看我们的团队

Over 65

completed deals

in the last 5 years

€9.4bn

deal value

over the last 5 years

Over 40%

deals involved PE

in the last 5 years

见解

  • Clearwater International Multiples Heatmap - Q4 2020

    A strong performance in the second half of the year meant that any drop-off in activity was not as pronounced as was first feared, with 2020 deal value and volume falling by just 5% and 6% year-on-year, respectively. At 11x, average multiples paid in PE-backed transactions across Europe reached a new high in the final quarter of the year.

    阅读更多
  • Spotlight on: France

    With a strong rebound in dealdoing after the Q2 2020 lockdown, the French PE market remains the busiest in Europe – and deal-hungry sponsors with deep pockets should ensure processes remain heated in the coming months.

    阅读更多
  • European overview

    This report identifies key themes driving European Private Equity (PE) deals’ EV/EBITDA multiples on a quarterly basis. Through illustrating key valuation trends across regions and sectors, we aim to support PE investors source better investment opportunities.

    阅读更多